A compound of formula: or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically acceptable salts or the solvates thereof; wherein X is CH and Y is CR 3, or one of X or Y is CR 3 and the other is nitrogen or X and Y are nitrogen; R 1 is selected from (i) N-linked pyrazolyl which is substituted on any of the carbon atoms with two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (ii) C-linked pyrazolyl which is optionally substituted on a nitrogen atom with a substituent selected from C 1-4 alkyl, hydroxyC 1-4 alkyl and haloC 1-4 alkyl, and further optionally substituted on the carbon atoms with one or two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iii) imidazolyl which is optionally substituted with one or two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iv) pyridinyl which is substituted with two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, and (v) triazolyl substituted with one substituent selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, =O and nitrile or two substituents independently selected from halogen, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile; R 2 is selected from: benzyl optionally substituted on the phenyl group by one or two substituents selected from fluorine and nitrile, and optionally substituted on the methylene by hydroxyl; and C 2-4 alkyl substituted by one or two substituents selected from fluorine and hydroxyl; and R 3 is selected from hydrogen and nitrile. X is CH and Y is CR 3, or one of X or Y is CR 3 and the other is nitrogen or X and Y are nitrogen; R 1 is selected from (i) N-linked pyrazolyl which is substituted on any of the carbon atoms with two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (ii) C-linked pyrazolyl which is optionally substituted on a nitrogen atom with a substituent selected from C 1-4 alkyl, hydroxyC 1-4 alkyl and haloC 1-4 alkyl, and further optionally substituted on the carbon atoms with one or two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iii) imidazolyl which is optionally substituted with one or two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iv) pyridinyl which is substituted with two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, and (v) triazolyl substituted with one substituent selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, =O and nitrile or two substituents independently selected from halogen, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile; (i) N-linked pyrazolyl which is substituted on any of the carbon atoms with two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (ii) C-linked pyrazolyl which is optionally substituted on a nitrogen atom with a substituent selected from C 1-4 alkyl, hydroxyC 1-4 alkyl and haloC 1-4 alkyl, and further optionally substituted on the carbon atoms with one or two substituents independently selected from C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iii) imidazolyl which is optionally substituted with one or two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, (iv) pyridinyl which is substituted with two substituents independently selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile, and (v) triazolyl substituted with one substituent selected from halogen, C 1-4 alkyl, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkyl, =O and nitrile or two substituents independently selected from halogen, hydroxyl, hydroxyC 1-4 alkyl, C 1-4 alkyoxy, haloC 1-4 alkyl, methoxymethyl, =O and nitrile; R 2 is selected from: benzyl optionally substituted on the phenyl group by one or two substituents selected from fluorine and nitrile, and optionally substituted on the methylene by hydroxyl; and C 2-4 alkyl substituted by one or two substituents selected from fluorine and hydroxyl; and R 3 is selected from hydrogen and nitrile.